Sleep Linked to Protection Against Nonalcoholic Fatty Liver Disease

May 16th 2022

Using a data set of more than 100,000 people, investigators found getting more than seven hours of sleep per night reduced the risk of developing fatty liver disease.

Dupixent Improves Severe Asthma Symptoms in a Real-World Setting, but Switching May Require Eosinophil Monitoring

May 16th 2022

Real-world study conducted in Japan shows Dupixent (dupilumab) reduced the number of annual severe asthma exacerbations b 53%, there were also adverse events associated with high eosinophil levels in patients who had switched from a different biologic before starting Dupixent.

Sleep Disturbances a Major Issue in Gynecological Cancer, Review Finds

May 15th 2022

Treatments like cognitive behavioral therapy for insomnia and exercise therapy can help address sleep problems, both during and after treatment, the study found.

FDA Updates for Week of May 9, 2022

May 14th 2022

In COVID-19 news, the FDA has approved Olumiant for new COVID-19 indication, but had limited Janssen’s COVID-19 vaccine. The agency has launched a new program for rare disease drug development and approved a new oral form of ALS therapy. Regulators have also extended the review time for both a new Pompe disease therapy and the sNDA for Myfembree for endometriosis. Additionally, Eisai has completed its submission of lecanemab for Alzheimer’s disease.

NIH Partners with WHO to Make COVID-19 Tech Available Worldwide

May 13th 2022

The partnership will allow international manufacturers to use the technologies for the potential development of COVID-19 vaccines, treatments and diagnostics to benefit people living in low- and middle-income countries.